Bioscience & Health Care



Existing treatment archetypes are being transformed throughout the bioscience & health
care industry in Arizona. The state is home to one-of-a-kind partnerships among teaching hospitals, research institutions, commercial companies, investors and foundations that
make it more efficient and effective to conduct research and commercialize new technology.


Arizona is dedicated to advancing improvements in diagnosing and treating cancer. With integrated, high-quality care, Arizona’s health care leaders are drafting radical new concepts for cancer treatment and diagnosis. The Mayo Clinic has developed a breakthrough treatment for aggressive forms of breast cancer and pancreatic cancer, while Ventana Medical Systems, part of the Roche Group, collaborates with leading pharmaceutical companies to develop companion diagnostics to better match patients to therapies.

Personalized Medicine

Diagnostics research and development is led by Arizona’s public universities in partnership with public and private institutions. These partnerships make the state a more efficient and effective location to conduct research and create entirely new types of products.
The Translational Genomics Research Institute (TGen) is a leader applying genomic analysis and bioinformatics to developing precision treatments and drugs for common
and complex diseases. HTG Molecular Diagnostics’ technology allows genetic profiling of
a tumor using a much smaller sample of the tumor than traditional technology.


Arizona’s specialized manufacturing supply chain serves the need for hyper customized products. Becton Dickson’s headquarters and manufacturing facilities are in Tempe, where the global medical technology company develops its biopsy and peripheral vascular devices. Arizona medical device developers are also drivers for digital transformation. From Medtronic’s electromedical devices and W. L. Gore’s implantable medical devices, diverse development and manufacturing companies support Arizona’s unparalleled medical device sector.


Arizona institutions play a major role in the research and treatment for Alzheimer’s, Parkinson’s and Lou Gehrig’s disease. The Barrow Neurological Institute at St. Joseph’s Hospital and Banner Sun Health Research Institute are just a couple of the many institutions leading the way in providing some of the most productive Alzheimer’s disease research programs in the world. Additionally, Banner Health recently expanded its Alzheimer’s services in Tucson with a comprehensive care center in partnership with the University of Arizona Department of Neurology.


In a fast-growing sector, pharmaceutical companies in Arizona discover next-generation therapies. Cutting-edge pharmaceutical development and testing in Arizona is driven by nationally recognized industry leaders. Icagen’s Tucson Research Center works in computational chemistry and ultra-high throughput screening to discover next-generation therapies for Sanofi and other clients. Tucson-based Critical Path Institute is dedicated to improving FDA processes to accelerate the pace and reduce the costs of medical innovation.


Health care providers are a key component of Arizona’s biomedical infrastructure. Hospitals and providers around Arizona also participate in cutting edge research through clinical trials and laboratory research, enabling new discoveries for patients around the world. Phoenix Children’s Hospital was named a “Best Children’s Hospital” by U.S. News & World Report, marking the eighth year it earned the prestigious ranking. Banner Health, a top health system in the nation and largest private employer in Arizona, is headquartered in Phoenix.